APEXIGEN INC (APGN)

US03759B1026 - Common Stock

0.3851  +0.03 (+8.48%)

After market: 0.3807 0 (-1.14%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
2.346M3.672M
56.52%		4.08M
11.11%		29.506M
623.19%		48.043M
62.82%		70.184M
46.09%		128.13M
82.56%		100.98M
-21.19%
EBITDA
YoY % growth
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-18.739M
50.65%		-20.646M
-10.18%		-31.81M
-54.08%		-41.307M
-29.86%		-58.34M
-41.23%		-75.683M
-29.73%		-54.913M
27.44%		114.24M
308.04%
Operating Margin
-798.76%-562.25%-779.66%-140.00%-121.43%-107.84%-42.86%113.13%
EPS
YoY % growth
-0.51
70.12%		-0.27
47.00%		-0.27
1.89%		-0.44
-65.38%		-0.45
-3.49%		-0.52
-14.61%		-0.36
31.37%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.29-0.36-0.19-0.19-0.19
32.14%		-0.08
77.57%
Revenue
Q2Q % growth		3.774M1.53M1.53M1.53M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-8.466M-8.56M-4.386M-4.896M-4.794M
43.37%		-4.896M
42.80%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 -0.24 -0.19-0.05-23.84%
Q1 2023
Q2Q % growth		 -0.25 -0.19-0.06-29.00%
Q4 2022
Q2Q % growth		 -0.33 -0.360.039.29%
Q3 2022
Q2Q % growth		 -0.41 -0.29-0.12-43.56%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A